Shuttle Pharmaceuticals Holdings (SHPH) Non Operating Income (2021 - 2026)

Shuttle Pharmaceuticals Holdings' Non Operating Income history runs 6 years deep, the most recent figure standing at $64351.0 for Q1 2026.

• On a quarterly basis, Non Operating Income rose 163.23% year-over-year to $64351.0 in Q1 2026; TTM through Mar 2026 was $361272.0, a 130.0% increase from a year earlier, with the FY2025 full-year figure at $195155.0, up 113.47% from the prior year.
• Non Operating Income slipped to $64351.0 in Q1 2026 per SHPH's latest filing, from $173340.0 in the prior quarter.
• Across five years, Non Operating Income topped out at $569683.0 in Q1 2023 and bottomed at -$2.2 million in Q4 2022.
• The 5-year median for Non Operating Income is -$176957.0 (2022), against an average of -$267159.1.
• Across the five-year window, Non Operating Income plunged 803.47% in 2022 and soared 1411.33% in 2023, its largest moves.
• Year by year, Non Operating Income stood at -$2.2 million in 2022, then surged by 83.65% to -$357676.0 in 2023, then surged by 149.95% to $178659.0 in 2024, then decreased by 2.98% to $173340.0 in 2025, then tumbled by 62.88% to $64351.0 in 2026.
• Per Business Quant, the three latest SHPH Non Operating Income figures stand at $64351.0 (Q1 2026), $173340.0 (Q4 2025), and -$80360.0 (Q3 2025).